Alexander Labrunerie & Co’s Pfizer PFE Stock Holding History

Alexander Labrunerie & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-111	Closed	-$153	–	128
2025 Q4	$153	Buy	+111	New	+$2.8K	﹤0.01%	118

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Alexander Labrunerie & Co's PFE Position: Q3 2025 in Review

Alexander Labrunerie & Co sold out of Pfizer (PFE) in Q3 2025, closing a stake of 61,941 shares — an estimated $1.5M sold.

Alexander Labrunerie & Co first reported a position in PFE in Q1 2024 and held it in 6 quarters. The position peaked at $1.57M in Q1 2025. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

Alexander Labrunerie & Co reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
Alexander Labrunerie & Co sold 61,941 Pfizer shares in Q3 2025, an estimated $1.5M.
Alexander Labrunerie & Co first reported a position in Pfizer in Q1 2024 and held it in 6 quarters.
Alexander Labrunerie & Co's Pfizer position peaked at $1.57M in Q1 2025.
2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Alexander Labrunerie & Co's 13F filing for Q3 2025, filed 25 Nov 2025.